Provided by Tiger Fintech (Singapore) Pte. Ltd.

COMPASS Pathways plc

3.94
-0.3500-8.16%
Post-market: 4.100.1600+4.06%18:56 EDT
Volume:2.02M
Turnover:8.39M
Market Cap:368.63M
PE:-2.03
High:4.38
Open:4.29
Low:3.92
Close:4.29
Loading ...

Compass Pathways Achieves Primary Endpoint in Phase 3 Trial for Psilocybin Treatment of Treatment-Resistant Depression

Reuters
·
23 Jun

European Equities Traded in the US as American Depositary Receipts Retreat Friday

MT Newswires Live
·
20 Jun

Compass Pathways plc Conducted Annual General Meeting of Shareholders

Reuters
·
13 Jun

European Equities Traded in the US as American Depositary Receipts Advance Friday

MT Newswires Live
·
06 Jun

Compass Pathways Coverage Assumed by Cantor Fitzgerald at Overweight

Dow Jones
·
27 May

Cantor Fitzgerald Reaffirms Their Buy Rating on COMPASS Pathways (CMPS)

TIPRANKS
·
27 May

Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference

Reuters
·
14 May

Compass Pathways Price Target Maintained With a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
12 May

Compass Pathways PLC reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
08 May

Compass Pathways Expects 2025 Net Cash Used In Operating Activities To Be In The Range Of $120M-$145M

Benzinga
·
08 May

Compass Pathways Q1 EPS $(0.24) Beats $(0.47) Estimate, Cash $260.1M

Benzinga
·
08 May

BRIEF-COMPASS Pathways Q1 EPS USD -0.2

Reuters
·
08 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

Compass Pathways PLC expected to post a loss of 47 cents a share - Earnings Preview

Reuters
·
06 May

H.C. Wainwright Keeps Their Buy Rating on COMPASS Pathways (CMPS)

TIPRANKS
·
01 May

BRIEF-Compass Pathways Establishes Strategic Collaboration With Healthport

Reuters
·
29 Apr

Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities

Business Wire
·
29 Apr

Compass Pathways to Announce First Quarter Financial Results on May 8, 2025

Business Wire
·
28 Apr

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Market Exclusive
·
28 Apr

Psychedelic: Clearmind completes clinical site initiations for AUD trial

TipRanks
·
25 Apr